
Flavie Strappazzon
Biography not available yet.
Events

23
Apr
2026
Seminar
Past
External
Huntingtin as a Regulator of Actin Architecture: Insights from Developing Cortical Circuits
Mariacristina Capizzi
Abstract Huntington’s disease (HD) is a monogenic neurodegenerative disorder caused by a CAG expansion in the HTT gene. The work […]
Amphi Hermann (1st floor), Faculté de Médecine Lyon-Est Rockefeller

07
Nov
2023
Seminar
Past
External
Selective autophagy of phase-separated p62: from molecular mechanism to pathophysiology
Pr Masaaki Komatsu
Médiathèque Paul Zech
Projects
Type:
Category:
Better characterize the beneficial role of a variant of the autophagic receptor NDP52 in the context of Alzheimer’s disease

Principal investigator
Flavie Strappazzon
Team: Autophagy in pathophysiology
Investigate the importance of mitophagy in the context of neurodevelopment

Principal investigator
Flavie Strappazzon

Principal investigator
Julien Courchet
Team: Autophagy in pathophysiology, Energy metabolism and neuronal development
Autophagy/mitophagy regulation in striated skeletal muscle and in the context of Myotonic Dystrophy type 1

Principal investigator
Flavie Strappazzon
Team: Autophagy in pathophysiology
Publications
2026
Autophagy and selective autophagy receptors: Key players against Alzheimer’s disease.,
Neural Regen Res 2026 Oct; 21(10): 4785-4797.
2026
A fetus with severe developmental defects caused by dominant-negative and hypomorphic ATG7 alleles.,
Autophagy 2026 Sep; 22(9): 2232-2247.
2026
α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis.,
Cell Mol Biol Lett 2026 Jun; 31(1): .
2026
Protocols for MCF-7 derived mammosphere generation and anti-cancer drug testing.,
Methods Cell Biol 2026 ; 206(): 145-154.
2025
NDP52 and its emerging role in pathogenesis.,
Cell Death Dis 2025 May; 16(1): 359.
2025
A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer’s disease.,
Cell Death Dis 2025 Apr; 16(1): 300.
2024
A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer Disease
Une variante du récepteur autophagique NDP52 contrecarre l’accumulation de phospho-TAU et apparaît comme un facteur de protection contre la maladie d’Alzheimer,
.
2024
miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition.,
Cell Death Discov 2024 Mar; 10(1): 149.
2024
Combining doxorubicin and miR-218-5p: a new strategy to fight breast cancer?,
Autophagy Reports.
2023
AMBRA1 phosphorylation by CDK1 and PLK1 regulates mitotic spindle orientation,
Cellular and Molecular Life Sciences.
2023
Apoptotic cell death in disease—Current understanding of the NCCD 2023,
Cell Death and Differentiation.
2023
Habilitation à Diriger des Recherches L’autophagie sélective au coeur de la physiopathologie,
.
2022
Cobalt chloride has beneficial effects across species through a hormetic mechanism,
Frontiers in Cell and Developmental Biology.
2022
Ambra1 deficiency impairs mitophagy in skeletal muscle.,
J Cachexia Sarcopenia Muscle 2022 Aug; 13(4): 2211-2224.
2021
Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy.,
Cell Death Differ 2021 Aug; 28(8): 2499-2516.
2021
A protective variant of the autophagy receptor CALCOCO2/NDP52 in Multiple Sclerosis (MS).,
Autophagy 2021 Jun; 17(6): 1565-1567.
2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.,
Autophagy 2021 Jan; 17(1): 1-382.


